Clinical Trial Update: Allergen Challenge Chamber Study With Single Dose Oral GSK835726 Compared With Placebo [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating a single-dose oral GSK835726 compared with placebo in seasonal allergic rhinitis has completed, using an allergen challenge chamber d…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Seasonal Allergic Rhinitis

Drugs mentioned

• GSK835726

Snippet

Sponsor: GlaxoSmithKline | Conditions: Rhinitis, Allergic, Seasonal | Phase 2 | Status: COMPLETED